Genprex

• locale

  United States

• market

  STOCKS

• industry

  Biotechnology

• website

  www.genprex.com

• ipo date

  Mar 29, 2018

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquarte...Show More